National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, China.
Department of Gastroenterology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
Cell Mol Gastroenterol Hepatol. 2021;12(2):395-425. doi: 10.1016/j.jcmgh.2021.02.013. Epub 2021 Mar 3.
BACKGROUND & AIMS: Rev-erbα represents a powerful transcriptional repressor involved in immunity. However, the regulation, function, and clinical relevance of Rev-erbα in Helicobacter pylori infection are presently unknown.
Rev-erbα was examined in gastric samples from H pylori-infected patients and mice. Gastric epithelial cells (GECs) were isolated and infected with H pylori for Rev-erbα regulation assays. Gastric tissues from Rev-erbα and wild-type (littermate control) mice or these mice adoptively transferred with CD4 T cells from IFN-γ and wild-type mice, bone marrow chimera mice and mice with in vivo pharmacological activation or inhibition of Rev-erbα were examined for bacteria colonization. GECs, CD45CD11cLy6GCD11bCD68 myeloid cells and CD4 T cells were isolated, stimulated and/or cultured for Rev-erbα function assays.
Rev-erbα was increased in gastric mucosa of H pylori-infected patients and mice. H pylori induced GECs to express Rev-erbα via the phosphorylated cagA that activated ERK signaling pathway to mediate NF-κB directly binding to Rev-erbα promoter, which resulted in increased bacteria colonization within gastric mucosa. Mechanistically, Rev-erbα in GECs not only directly suppressed Reg3b and β-defensin-1 expression, which resulted in impaired bactericidal effects against H pylori of these antibacterial proteins in vitro and in vivo; but also directly inhibited chemokine CCL21 expression, which led to decreased gastric influx of CD45CD11cLy6GCD11bCD68 myeloid cells by CCL21-CCR7-dependent migration and, as a direct consequence, reduced bacterial clearing capacity of H pylori-specific Th1 cell response.
Overall, this study identifies a model involving Rev-erbα, which collectively ensures gastric bacterial persistence by suppressing host gene expression required for local innate and adaptive defense against H pylori.
REV-ERBα 是一种强大的转录抑制因子,参与免疫反应。然而,REV-ERBα 在幽门螺杆菌(H.pylori)感染中的调控、功能和临床相关性目前尚不清楚。
在 H.pylori 感染患者和小鼠的胃组织样本中检测 Rev-erbα。分离胃上皮细胞(GECs),并用 H.pylori 感染进行 Rev-erbα 调控分析。用 Rev-erbα 和野生型(同窝对照)小鼠或从 IFN-γ 和野生型小鼠过继转移 CD4 T 细胞的这些小鼠、骨髓嵌合体小鼠以及体内药理学激活或抑制 Rev-erbα 的小鼠的胃组织,检测细菌定植情况。分离、刺激和/或培养 GECs、CD45CD11cLy6GCD11bCD68 髓样细胞和 CD4 T 细胞,进行 Rev-erbα 功能分析。
Rev-erbα 在 H.pylori 感染患者和小鼠的胃黏膜中增加。H.pylori 通过磷酸化 cagA 诱导 GECs 表达 Rev-erbα,激活 ERK 信号通路,直接介导 NF-κB 与 Rev-erbα 启动子结合,从而导致胃黏膜内细菌定植增加。在机制上,GECs 中的 Rev-erbα 不仅直接抑制 Reg3b 和 β-防御素-1 的表达,导致这些抗菌蛋白在体外和体内对 H.pylori 的杀菌作用受损;还直接抑制趋化因子 CCL21 的表达,导致 CCL21-CCR7 依赖性迁移减少胃内 CD45CD11cLy6GCD11bCD68 髓样细胞的流入,作为直接后果,降低了 H.pylori 特异性 Th1 细胞反应的细菌清除能力。
总之,本研究确定了一个涉及 Rev-erbα 的模型,该模型通过抑制宿主基因表达,共同确保了胃内细菌的持续存在,这些基因表达是局部固有和适应性防御 H.pylori 所必需的。